Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus

Physiological Genomics

Volumn 29, Issue 1, 2007, Pages 13-23

  Ivanga, Mahinè ^a   Labrie, Yvan ^a   Calvo, Ezequiel ^a   Belleau, Pascal ^a   Martel, Céline ^a   Luu The, Van ^a   Morissette, Jean ^a   Labrie, Fernand ^a   Durocher, Francine ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

17 estradiol; 17 estradiol modulation; Oligonucleotide microarray; Ovariectomized mice; Protein tyrosine phosphatase

Indexed keywords

ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOARCHITECTURE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UPREGULATION; UTERUS;

ANIMALS; CELL CYCLE PROTEINS; DNA PRIMERS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; UTERUS;

MUS;

EID: 34248141580     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00291.2005     Document Type: Article

References (74)

1. Adamski J, Ma Z, Nozell S, Benveniste EN. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol Endocrinol 18: 1963-1974, 2004.
2. Azam N, Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA. Interaction of CR6 (GADD45gamma) with proliferating cell nuclear antigen impedes negative growth control. J Biol Chem 276: 2766-2774, 2001.
3. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, Efstratiadis A. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 10: 903-918, 1996.
4. Bar RS, Booth BA, Boes M, Dake BL. Insulin-like growth factor-binding proteins from vascular endothelial cells: purification, characterization, and intrinsic biological activities. Endocrinology 125: 1910-1920, 1989.
5. Bhalla US, Ram PT, Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase network. Science 297: 1018-1023, 2002.
6. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, Marra F. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. Biol Chem 276: 9945-9954, 2001.
7. Buckley DA, Loughran G, Murphy G, Fennelly C, O'Connor R. Identification of an IGF-1R kinase regulatory phosphatase using the fission yeast Schizosaccharomyces pombe and a GFP tagged IGF-1R in mammalian cells. Mol Pathol 55: 46-54, 2001.
8. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36: 433-445, 1981.
9. Càrdenas H, Pope WF. Attenuation of estrogenic effects by dihydrotestosterone in pig uterus is associated with downregulation of the estrogen receptors. Biol Reprod 70: 297-302, 2004.
10. Cates CA, Michael RL, Stayrook KR, Harvey KA, Burke YD, Randall SK, Crowell PL, Crowell DN. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 110: 49-55, 1996.
11. Chuang CF, Ng SY. Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors. FEBS Lett 346: 229-234, 1994.
12. Cicatiello L, Sica V, Bresciani F, Weisz A. Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor 3: 17-30, 1993.
13. Cuddeback SM, Yamaguchi H, Komatsu K, Miyashita T, Yamada M, Wu C, Singh S, Wang HG. Molecular cloning and characterization of Bif-1: a novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 276: 20559-20565, 2001.
14. de Jager T, Pelzer T, Muller-Botz S, Imam A, Muck J, Neyses L. Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 276: 27873-27880, 2001.
15. Delehedde M, Sergeant N, Lyon M, Rudland PS, Fernig DG. Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways. Eur J Biochem 268: 4423-4429, 2001.
16. Deligdisch L, Holinka CF. Endometrial carcinoma: two diseases? Cancer Detect Prev 10: 237-246, 1987.
17. Dieudonne MN, Pecquery R, Leneuveu MC, Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex- and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor g2. Endocrinology 141: 649-656, 2000.
18. Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142: 44-52, 2005.
19. Dubik D, Shiu RP. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992.
20. Farquhar CM. Extracts from the "clinical evidence." Endometriosis BMJ 320: 1449-1452, 2000.
21. Flamigni F, Facchini A, Giordano E, Tantini B, Stefanelli C. Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors. Biochem Pharmacol 61: 25-32, 2001.
22. Girvigian MR, Nakatani A, Ling N, Shimasaki S, Erickson GF. Insulin-like growth factor binding proteins show distinct patterns of expression in the rat uterus. Biol Reprod 51: 296-302, 1994.
23. Goss PE, Qi S, Cheung AM, Hu H, Mendes M, Pritzker KPH. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats. J Steroid Biochem 92: 79-87, 2004.
24. 2-terminal activation domain of c-Myc. FEBS Lett 353: 281-285, 1994.
25. Guzeloglu-Kayisli O, Kayisli UA, Luceli G, Arici A. In vivo and in vitro regulation of AKT activation in human endometrial cells is estrogen dependent. Biol Reprod 71: 714-721, 2004.
26. Hewitt SC, Collins J, Grissom S, Deroo B, Korach KS. Global uterine genomics in vivo: microarray evaluation of the estrogen receptor alpha-growth factor cross-talk mechanism. Mol Endocrinol 19: 657-668, 2005.
27. Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA, Korach KS. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 17: 2070-2083, 2003.
28. Hickey M, Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech 60: 377-389, 2003.
29. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70, 2003.
30. Huynh H. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I. Int J Oncol 12: 427-432, 1998.
31. Inoue A, Takeuchi S, Takahashi S. Insulin-like growth factor-I stimulated DNA replication in mouse endometrial stromal cells. J Reprod Dev 51: 305-313, 2005.
32. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144: 2870-2881, 2003.
33. Kawakami A, Nakashima T, Tsuboi M, Urayama S, Matsuoka N, Ida H, Kawabe Y, Sakai H, Migita K, Aoyagi T, Nakashima M, Maeda K, Eguchi K. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochem Biophys Res Commun 247: 46-51, 1998.
34. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 276: 49066-49076, 2001.
35. Liu ML, Xu X, Rang WQ, Li YJ, Song HP. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int J Cardiol 97: 485-493, 2004.
36. Loose-Mitchell DS, Chiappetta C, Stancel GM. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 2: 946-951, 1988.
37. Luu-The V, Paquet N, Calvo E, Cumps J. Improved Real-Time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 8: 287-293, 2005.
38. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32: 569-577, 2001.
39. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 270: H142-H150, 1996.
40. Moggs JG, Tinwell H, Spurway T, Chang HS, Pate I, Lim FL, Moore DJ, Soames A, Stuckey R, Currie R, Zhu T, Kimber I, Ashby J, Orphanides G. Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect 112: 1589-1606, 2004.
41. Molnar P, Murphy LJ. Effects of oestrogen on rat uterine expression of insulin-like growth factor-binding proteins. J Mol Endocrinol 13: 59-67, 1994.
42. Moreno-Bueno G, Sànchez-Estévez C, Cassia R, Rodriguez-Perales S, Diaz-Uriarte R, Dominguez O, Hardisson D, Andujar M, Prat J, Matias-Guiu X, Cigudosa JC, Palacios J. Differential gene expression profile in endometrioid and nonendometrioid carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res 63: 5697-5702, 2004.
43. Moyano P, Rotwein P. Mini-review: estrogen action in the uterus and insulin-like growth factor-I. Growth Horm IGF Res 14: 431-435, 2004.
44. Muda M, Boschert U, Dickinson R, Martinou JC, Martinou I, Camps M, Schlegel W, Arkinstall S. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 271: 4319-4326, 1996.
45. Mutch DM, Berger A, Mansourian R, Rytz A, Roberts MA. The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics 3: 17, 2002.
46. Newman JC, Weiner AM. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol 6: R81, 2005.
47. Niklaus AL, Aberdeen GW, Babischkin JS, Pepe GJ, Albrecht ED. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium. Biol Reprod 68: 1997-2004, 2003.
48. O'Connor R. Regulation of IGF-1 receptor signaling in tumor cells. Horm Metab Res 35: 771-777, 2003.
49. Ouban A, Muraca P, Yeatman T, Coppola D. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol 34: 803-808, 2003.
50. Paharkova-Vatchkova V, Maldonado R, Kovats S. Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 172: 1426-1436, 2004.
51. Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun 304: 505-512, 2003.
52. Pelletier G, Luu-The V, Li S, Labrie F. Localization and estrogenic regulation of androgen receptor mRNA expression in the mouse uterus and vagina. J Endocrinol 180: 77-85, 2004.
53. Perillo B, Sasso A, Abbondanza C, Palumbo G. 17beta-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901, 2000.
54. Picard F, Deshaies Y, Lalonde J, Samson P, Labrie C, Belanger A, Labrie F, Richard D. Effects of the estrogen antagonist EM-652. HCl on energy balance and lipid metabolism in ovariectomized rats. Int J Obes Relat Metab Disord 24: 830-840, 2000.
55. Pulido R, Zuniga A, Ullrich A. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J 17: 7337-7350, 1998.
56. Richards RG, Diaugustine RP, Petrusz P, Clark GC, Sebastian J. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci USA 93: 12002-12007, 1996.
57. Risinger JI, Maxwell GL, Chandramouli GVR, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC. Microarray analysis reveals distinct gene expression profiles among histologic types of endometrial cancer. Cancer Res 63: 6-11, 2003.
58. Russell DH, Taylor RL. Polyamine synthesis and accumulation in the castrated rat uterus after estradiol-17-beta stimulation. Endocrinology 88: 1397-1403, 1971.
59. Salmeen A, Anderson JN, Myers MP, Tonks NK, Bradford D. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6: 1401-1412, 2000.
60. Sato T, Wang G, Hardy MP, Kurita T, Cunha GR, Cooke PS. Role of systemic and local IGF-1 in the effects of estrogen on growth and epithelial proliferation of mouse uterus. Endocrinology 143: 2673-2679, 2002.
61. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493, 1993.
62. Takeda-Matsubara Y, Nakagami H, Iwai M, Cui TX, Shiuchi T, Akishita M, Nahmias C, Ito M, Horiuchi M. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 39: 41-45, 2002.
63. Tan YF, Li FX, Piao YS, Sun XY, Wang YL. Global gene profiling analysis of mouse uterus during the oestrus cycle. Reproduction 126: 171-182, 2003.
64. Tang XM, Rossi MJ, Masterson BJ, Chegini N. Insulin-like growth factor I (IGF-1), IGF-1 receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-1 action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 50: 1113-1125, 1994.
65. Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T, Kohno M. Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J Biol Chem 277: 28256-28264, 2002.
66. Tong W, Pollard JW. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19: 2251-2264, 1999.
67. Vairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA. Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control. J Biol Chem 275: 16810-16819, 2000.
68. Vincent AM, Feldman EL. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12: 193-197, 2002.
69. Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M. Comparison of human adult and fetal expression and identification of 535 housekeeping/ maintenance genes. Physiol Genomics 2: 143-147, 2000.
70. Watanabe H, Suzuki A, Kobashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H, Iguchi T. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J Mol Endocrinol 30: 347-358, 2003.
71. Weihua Z, Ekman J, Almkvist A, Saji S, Wang L, Warner M, Gustafsson JA. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus. Biol Reprod 67: 616-623, 2002.
72. Wing LY. Effect of estradiol on the activities of ornithine decarboxylase and S-adenosyl-methionine decarboxylase in tissues of ovariectomized rats. Chin J Physiol 31: 95-103, 1988.
73. Zhang ZY. Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 5: 416-423, 2001.
74. Zhang ZY, Zhou B, Xie L. Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol Ther 93: 307-317, 2002.